T cell homeostatic proliferation elicits effective antitumor autoimmunity

Journal of Clinical Investigation

Volumn 110, Issue 2, 2002, Pages 185-192

  Dummer, Wolfgang ^a   Niethammer, Andreas G ^a   Baccala, Roberto ^a   Lawson, Brian R ^a   Wagner, Norbert ^b   Reisfeld, Ralph A ^a   Theofilopoulos, Argyrios N ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b KLINIKUM DORTMUND   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; CELLULAR IMMUNITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; HOMEOSTASIS; INTERFERON PRODUCTION; LONG TERM MEMORY; LYMPHOCYTOPENIA; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY;

EID: 0036076114     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215175     Document Type: Article

References (40)

1. Progress in human tumour immunology and immunotherapy
2. Cancer tumor antigens
3. Therapeutic vaccination for cancer
4. Induction of anti-self-immunity to cure cancer
5. Cancer antigens: Immune recognition of self and altered self
6. Immunity against cancer: Lessons learned from melanoma
7. Autoimmunity and the immunotherapy of cancer: Targeting the "self" to destroy the "other"
8. The risk of autoimmunity associated with tumor immunotherapy
9. Dendritic cells and tumor immunity
10. Dendritic cells: On the move from bench to bedside
11. Restoration of T-cell homeostasis after T-cell depletion
12. Selecting and maintaining a diverse T-cell repertoire
13. Homeostatic T cell proliferation. How far can T cells be activated to self-ligands?
14. Homeostasis of alpha/beta TCR+ T cells
15. T cell homeostasis and systemic autoimmunity
16. Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone
17. Isolation of GD3 synthase gene by expression cloning of GM3 α-2,8-sialtransferase cDNA using anti-CD2 monclonal antibody
18. Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy
19. + suppressor T cells in vivo
20. Autologous regulation of naive T cell homeostasis within the T cell compartment
21. The role of CD4+ T cell responses in anti-tumor immunity
22. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockage and depletion of CD25+ regulatory T cells in anti-tumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses
23. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune viriligo and tumor cell destruction in mice: Requirement for CD4(+) T lymphocytes
24. Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen
25. MHC-II-independent CD4+ T cells induce colitis in immunodeficient RAG-/-hosts
26. Non-lymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells
27. Epitope affinity for MHC class I determines helper requirement for CTL priming
28. + T cells: CD4-independent help
29. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
30. Lymphotoxin-alpha-deficient mice: Effects on secondary lymphoid organ development and humoral immune responsiveness
31. L-selectin and β7 integrin synergistically mediate lymphocyte migration to mesenteric lymph nodes
32. Cutting edge: Naive T cells masquerading as memory cells
33. Naive cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients: A pitfall for T cell memory studies?
34. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells
35. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction
36. Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: Implications for generating CD8+ T cell responses to infectious agents, tumors, transplants and vaccines
37. Cross-presentation, dendritic cells, tolerance and immunity
38. Dependence of lymphopenia-induced T cell proliferation on the abundance of peptide/MHC epitopes and strength of their interaction with T cell receptors
39. Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery
40. Homeostasis-driven proliferation sensitizes T cells to cross-priming by a prostate tumor vaccine